Home/Avammune Therapeutics/Aditya Kulkarni
AK

Aditya Kulkarni

Founder & CSO

Avammune Therapeutics

Therapeutic Areas

Avammune Therapeutics Pipeline

DrugIndicationPhase
AVA-NP-695Solid TumorsPreclinical
AVA-ADRSolid TumorsPreclinical
AVA-ERLSolid TumorsPreclinical